tiprankstipranks
Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV

Plus Therapeutics (PSTV) Financial Statements

535 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.185; its P/E ratio is -0.49; Plus Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.68M$ 1.24M$ 1.85M$ 506.00K$ 224.00K
Gross Profit$ 1.68M$ 1.24M$ 1.85M$ 506.00K-
EBIT$ -3.23M$ -3.13M$ -1.37M$ -4.67M$ -5.50M
EBITDA$ -3.02M$ -2.89M$ -1.13M$ -4.42M$ -5.34M
Net Income Common Stockholders$ -3.26M$ -3.22M$ -1.48M$ -4.80M$ -5.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.22M$ 11.01M$ 10.89M$ 12.72M$ 18.12M
Total Assets$ 5.62M$ 13.28M$ 14.20M$ 15.64M$ 23.87M
Total Debt$ 3.76M$ 4.58M$ 4.96M$ 5.33M$ 5.64M
Net Debt$ 540.00K$ -6.42M$ -5.94M$ -7.39M$ -12.47M
Total Liabilities$ 10.46M$ 10.66M$ 11.54M$ 12.96M$ 17.42M
Stockholders Equity$ -4.84M$ 2.62M$ 2.63M$ 2.68M$ 6.45M
Cash Flow-
Free Cash Flow$ -4.54M$ -2.41M$ -2.81M$ -5.88M$ -2.25M
Operating Cash Flow$ -4.50M$ -2.40M$ -2.80M$ -5.79M$ -2.23M
Investing Cash Flow$ -364.00K$ -10.00K$ -11.00K$ -97.00K$ -11.00K
Financing Cash Flow$ -776.00K$ 2.52M$ 961.00K$ 493.00K$ 99.00K
Currency in USD

Plus Therapeutics Earnings and Revenue History

Plus Therapeutics Debt to Assets

Plus Therapeutics Cash Flow

Plus Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis